Related by context. Frequent words. (Click for all words.) 72 cognitive impairment associated 70 thetreatment 67 sorafenib tablets 66 rheumatoid arthritis inflammatory bowel 66 refractory chronic lymphocytic 66 rufinamide 65 inhibits Akt activation 65 hepatitis C lupus 64 TNF blocking 64 psoriasis rheumatoid arthritis 64 neuroleptic 64 Lu AA# 63 R sorafenib tablets 63 neuro inflammatory 63 rheumatoid arthritis psoriatic arthritis 63 immune modulating 62 relapsed refractory AML 62 lysosomal storage disorder 62 epilepsy multiple sclerosis 62 autoimmune disorders asthma 62 PNP inhibitor 62 rheumatoid arthritis multiple sclerosis 62 neovascular age 62 oral antidiabetic 62 inflammation autoimmune diseases 62 mso pagination widow 62 bipolar disorder schizophrenia 62 multiple sclerosis rheumatoid arthritis 61 oral antiviral 61 rheumatoid arthritis psoriasis 61 premenstrual dysphoric disorder 61 Panzem R 61 insulin sensitizing 61 combines Zetia 61 rheumatoid arthritis lupus 61 hormone refractory metastatic prostate 61 Romidepsin 61 cirrhosis liver failure 60 inhibit angiogenesis 60 Major Depressive Disorder MDD 60 antiepileptic 60 CDP# 60 Valdoxan 60 recurrent glioblastoma multiforme 60 SSRI antidepressant 60 antidiabetic 60 dexanabinol 60 cediranib 60 KRN# 60 Tyrima 60 urinary bladder wall 60 TTR amyloidosis 60 neuropsychiatric disorder 60 Temsirolimus 60 dizziness imbalance 60 Enzastaurin 60 Panzem R NCD 60 commercial bioproduction 60 overactive bladder AA# 60 oral anticancer 60 infected aneurysms endocarditis 60 content VENDOR WHITE PAPER 60 Comorbid 59 cystic fibrosis inflammation autoimmune 59 Voreloxin 59 Lubiprostone 59 ® bortezomib 59 ziconotide 59 diabetic peripheral neuropathic DPN 59 HMG CoA reductase inhibitors 59 atypical antipsychotic 59 Parkinson disease multiple sclerosis 59 Lennox Gastaut syndrome 59 cromolyn sodium 59 pseudobulbar affect PBA 59 forodesine 59 Genasense ® 59 serotonin norepinephrine reuptake inhibitors 59 immunodeficiencies 59 #:#-#,# CrossRef Medline [002] 59 muscle paralyzing 59 ankylosing spondylitis psoriatic arthritis 59 phenylketonuria PKU developed 59 Eraxis 59 Milnacipran 59 Parkinson Disease PD 59 Meets Primary Endpoint 59 erlotinib Tarceva 59 clobazam 59 Belimumab 59 Pimavanserin 59 SNT MC# 59 Auxilium transmucosal film 59 Sapacitabine 59 neuromuscular dysfunction 59 gets USFDA nod 58 nasal pharyngeal cancer 58 metformin sulfonylurea 58 Treatment Resistant 58 anticlotting 58 acute leukemias